Zhejiang Jingxin Pharmaceutical Co., Ltd.
Simbol: 002020.SZ
SHZ
12.29
CNYPrețul de piață astăzi
16.3059
Raportul P/E
-1.6917
Raportul PEG
10.58B
MRK Cap
- 0.02%
Randament DIV
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020-SZ) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 7335.53 | 2019.9 | 1915.4 | 1977.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1127.56 | 609.3 | 366.9 | 422.4 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 2431.47 | 664 | 570 | 586.7 | |||||||||||||||||||||||
balance-sheet.row.inventory | 2703.54 | 652.7 | 773.7 | 649.1 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 299.73 | 17.1 | 22.1 | 16.5 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 12770.27 | 3353.7 | 3281.2 | 3229.5 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8656.05 | 2309.8 | 1632.1 | 1262.9 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 1393.94 | 348.5 | 348.5 | 257.9 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1617.31 | 401.3 | 418.6 | 137.7 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3011.25 | 749.7 | 767.1 | 395.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2754.28 | 1471.1 | 218.9 | 119.5 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 297.88 | 81 | 75.1 | 62.5 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 4007.56 | 21.2 | 1388.1 | 1345.3 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 18727.02 | 4632.8 | 4081.4 | 3185.8 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 3316.2 | 610.8 | 719.1 | 435.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 1704.65 | 621.3 | 253.3 | 161.9 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 199.19 | 44.3 | 105.4 | 95 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 139.56 | 31.2 | 43 | 6.6 | |||||||||||||||||||||||
Deferred Revenue Non Current | 1091.72 | 268.8 | 270.6 | 128.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 254.92 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 805.52 | 789.3 | 761.9 | 4.7 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1227.33 | 102.8 | 375.2 | 192.6 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 139.56 | 31.2 | 43 | 6.5 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 9357.68 | 2177.6 | 2190.6 | 1577.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 3444.12 | 861 | 861 | 905.3 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9981.01 | 2540.1 | 2228.8 | 1871.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4893.06 | 388 | 336.1 | 285.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3443.45 | 1723.3 | 1720.2 | 1755.1 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 21761.63 | 5512.4 | 5146.1 | 4817.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 109.17 | 27.8 | 25.8 | 20.2 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 21870.8 | 5540.2 | 5172 | 4837.7 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 31497.29 | - | - | - | |||||||||||||||||||||||
Total Investments | 3881.85 | 2080.4 | 585.8 | 541.9 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 1844.21 | 652.5 | 296.3 | 168.5 | |||||||||||||||||||||||
balance-sheet.row.net-debt | -4363.76 | -758.2 | -1252.2 | -1386.3 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 638.91 | 618.9 | 667.8 | 614.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 10.99 | 221.5 | 166.9 | 143.6 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 2.8 | -12.2 | -5.8 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -488 | 12.2 | 5.8 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 29.56 | -45 | 21.3 | -391.7 | ||||||||||||||||||||||
cash-flows.row.account-receivables | -93.48 | -93.5 | -250.9 | -208.6 | ||||||||||||||||||||||
cash-flows.row.inventory | 123.04 | 123 | -103 | -147.8 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -74.6 | 387.4 | -41.8 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -12.2 | 6.5 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 275.34 | 514.5 | -0.3 | -1.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 954.8 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 9.85 | 10.3 | 5.2 | 8.3 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -870.2 | -1175.2 | -1058 | -861.7 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1011.18 | 915 | 833.9 | 1407.9 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 311.97 | 0 | -3.2 | -5.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -189.34 | -769.4 | -737.7 | 144.7 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | -339.22 | -35 | -150 | -300.3 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | -258.11 | -258.3 | -258.6 | -232.2 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 593.64 | -4 | 220.5 | 653.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -180.91 | -245.6 | -188 | 120.8 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 5.78 | 2.7 | 14.9 | -3.8 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 684.27 | -77.8 | -55 | 626.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 5962.04 | 1410.6 | 1463.7 | 1512.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 5277.77 | 1488.5 | 1518.7 | 886 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 954.8 | 824.7 | 855.8 | 365 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 615.02 | 305.2 | 340.2 | -39.4 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 4082.46 | 3952.1 | 3779.8 | 3336 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2026.66 | 2048.3 | 1766.1 | 1472.8 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 2055.8 | 1903.8 | 2013.7 | 1863.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 410.79 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 78.1 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1442.43 | 1324.6 | 1354.4 | 1250.3 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3469.09 | 3372.9 | 3120.5 | 2723 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 43.91 | 60.3 | 65.6 | 48.1 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 82.38 | 221.5 | 182.9 | 170.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 740.39 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 658.01 | 579.2 | 756.6 | 693 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 735.28 | 714.1 | 750.3 | 694.5 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 90.4 | 84.6 | 82.5 | 79.8 | |||||||||||||||||||||||
income-statement-row.row.net-income | 638.91 | 618.9 | 662.3 | 612.5 |
Întrebări frecvente
Ce este Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) totalul activelor?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) activele totale sunt 7986556907.000.
Care este venitul anual al întreprinderii?
Venitul anual este 2117348157.000.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.504.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este 0.718.
Care este marja de profit net a întreprinderii?
Marja profitului net este 0.157.
Care este venitul total al întreprinderii?
Venitul total este 0.161.
Care este Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) profitul net (venitul net)?
Profitul net (venitul net) este 618898033.000.
Care este datoria totală a firmei?
Datoria totală este 652489982.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 1324586158.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 2069633166.000.